Cornovus Pharmaceuticals Inc. — Form D
Cornovus Pharmaceuticals Inc. of FARMINGTON, CT, a company, filed a Form D exempt-offering notice with the SEC on 2016-08-11. The offering totals $2.3M, of which $983K was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2016-08-11
- Form: D
- Accession: 0001600112-16-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $2.3M
- Amount sold: $983K
- Remaining: $1.3M
- Minimum investment: $1
- Investors: 2
- Date of first sale: 2016-08-10
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-268722
Issuer
- Name: Cornovus Pharmaceuticals Inc.
- CIK: 0001600112
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2011
- Address: 400 FARMINGTON AVENUE, FARMINGTON, CT, 06032
- Phone: 860-679-7894
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Bruce Liang | Director | Avon, CT |
| Glenn Mattes | Director | San Marcos, CA |
| Raymond Neag | Director | Wyomissing, PA |
| Timothy Shannon | Director | Stamford, CT |
| Daniel Wagner | Director | Branford, CT |
| Glenn Mattes | Executive Officer | San Marcos, CA |
| R. Mark Van Allen | Executive Officer | Farmington, CT |
| Robert Mark Van Allen | Executive Officer | New Haven, CT |
Other filings by this issuer (2)
More